Intradigm
http://www.intradigm.com/Overview
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Oct 3, 2008 | Funding round | $18.5M | |
| Nov 21, 2006 | Funding round | $16M |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 3, 2008 | Intradigm lands $18.5M to advance oncology treatment | Intradigm, a biotech company that develops RNA interference treatments for cancer, announced today that it took $18.5 million in a second round of financing that included new investors Lilly Ventures, Roche Venture Fund, MP Healthcare Ventu... |
| Nov 21, 2006 | Intradigm, a gene targeting co., raises $16M | Intradigm, a Palo Alto biotech company that is using a technology called “RNA interference” (RNAi) to target genes while providing oncology medical treatments, has raised $16 million in a first round of funding. It has also moved to Palo Al... |
Reviews 0
FAQ about Intradigm
When was Intradigm founded?
Intradigm was founded in 1994.
How much funding has Intradigm raised?
Intradigm has raised $55.9M in total across 3 funding rounds.
What funding rounds has Intradigm raised?
Parsers VC lists 3 funding rounds of Intradigm, among them a funding round of $18.5M on Oct 3, 2008 and a funding round of $16M on Nov 21, 2006.
What has the press written about Intradigm?
Parsers VC has collected 3 articles mentioning Intradigm, among them “Intradigm lands $18.5M to advance oncology treatment” (Oct 3, 2008) and “Intradigm, a gene targeting co., raises $16M” (Nov 21, 2006).
Is Intradigm still active?
Intradigm is probably closed: its latest activity on Parsers VC dates from Jan 7, 2009.